Recent Post
Related Posts
Parkinson 8217 s awareness month
Parkinson s disease psychosis is a
IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer’s Research
By: Faith Ashmore Benzinga Staff Writer As of 2023, the estimated number of Americans living with Alzheimer’s disease was 6.7 million. However, a lesser-known subsection of Alzheimer’s is Agitation in dementia from
By: Faith Ashmore Benzinga Staff Writer Alzheimer’s disease, a progressive neurological disorder, affects around 24 million individuals worldwide. It is characterized by memory loss, cognitive decline and behavioral changes. The impact
Synesthesia is a complex experience that involves perceiving the elements of the world with more than one sense By integrating the knowledge of neuroscience with these aspects of perception scientists
Artificial Intelligence and Alzheimer’s Disease
In Alzheimer 8217 s disease research the integration of artificial intelligence AI enables researchers to uncover patterns and biomarkers faster facilitating earlier diagnosis and personalized therapies Embracing these new technologies
COMPANY
